• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Caliper Life Sciences ends 2009 at a loss

Caliper Life Sciences ends 2009 at a loss

March 12, 2009 By MassDevice staff

Caliper Life Sciences Inc. took a big fourth-quarter hit to its balance sheet, widening its losses by 91 percent for the three-month period ended Dec. 31, 2008.

The Hopkinton-based lab equipment maker posted a $45 million charge on impairment of goodwill during the quarter.

That pushed the Caliper’s quarterly net loss to $46 million, compared to $5.7 million during the same period in 2007 — nearly 33 percent of its $68 million net loss for the full year. That, in turn, represents a 60 percent hike over the $24 million net loss Caliper posted for fiscal 2007.

Sales also declined, sliding 8.3 percent to $36.7 million for the quarter (compared with $40 million during the fourth quarter of the prior year) and dipping 4.4 percent, to $134 million, for the full year compared with $140 million in 2007.

Caliper said the goodwill charge stemmed from the divestiture of a pair of its product lines late last year.

The company sold its Pharmaceutical Development and Quality product line to Sotax Corp. for about $14 million in cash and the assumption of another $2 million in debt.

And in November 2008, Caliper sold AutoTrace automated water sample testing business Nov. 10, 2008 to Dionex Corp. for about $5 million in cash. The deal included provisions for Caliper to continue to manufacture and sell the product line through January of this year.

The deals netted Caliper roughly $19 million in cash and removed about $2 million in debts from the books, leaving it about $26 million in cash on hand at the end of 2008, compared to roughly $19 million for 2007.

But in the third quarter last year the company determined that its fair value (the likely price a buyer would pay for the company) exceeded its book value. Slumping sales and plunging share values — Caliper’s stock has fallen by about 75 percent since March 2008 — forced it to take the $45 million goodwill write-off during the fourth quarter.

Caliper said it expects sales of $25 million to $28 million for the first quarter and $122 million for the full year.

The company also announced a $25 million amended credit facility agreement with Silicon Valley Bank, effective through Nov. 30, 2010.

Filed Under: Business/Financial News, Lab Instruments & Supplies

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy